
USA - NASDAQ:TLMD - Common Stock
The current stock price of TLMD is 3 null. In the past month the price increased by 3.45%. In the past year, price decreased by -56.65%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.36 | 98.69B | ||
| CI | THE CIGNA GROUP | 9.49 | 71.98B | ||
| LH | LABCORP HOLDINGS INC | 16.87 | 22.18B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.15 | 20.90B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 106.07 | 19.17B | ||
| GH | GUARDANT HEALTH INC | N/A | 11.77B | ||
| DVA | DAVITA INC | 13.17 | 8.69B | ||
| HIMS | HIMS & HERS HEALTH INC | 68.48 | 8.36B | ||
| CHE | CHEMED CORP | 19.8 | 6.35B | ||
| RDNT | RADNET INC | 197.76 | 5.78B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 31.37 | 5.67B | ||
| OPCH | OPTION CARE HEALTH INC | 19.07 | 4.61B |
SOC Telemed, Inc. engages in the provision of acute care telemedicine services and technology to U.S. hospitals and healthcare. The company is headquartered in Herndon, Virginia and currently employs 226 full-time employees. The company went IPO on 2019-12-17. The firm provides technology enabled clinical solutions, which include acute teleNeurology, telePsychiatry, and teleICU. The firm offers technology platform, Telemed IQ that allows hospitals, health systems and other healthcare organizations the ability to provide telemedicine programs either with their its clinical team or in conjunction with its affiliated network of established, board-certified physicians and other provider specialists. Its cloud based Telemed IQ technology platform is an integrated and configurable technology solution that seamlessly combines voice, video, imaging, electronic medical record (EMR) integration, clinical workflow optimization, clinical resource management, analytics, predictive modeling and other reporting tools.
SOC TELEMED INC
2411 Dulles Corner Park, Suite 475
Herndon VIRGINIA 20190 US
CEO: John W. Kalix
Employees: 226
Phone: 18664839690.0
SOC Telemed, Inc. engages in the provision of acute care telemedicine services and technology to U.S. hospitals and healthcare. The company is headquartered in Herndon, Virginia and currently employs 226 full-time employees. The company went IPO on 2019-12-17. The firm provides technology enabled clinical solutions, which include acute teleNeurology, telePsychiatry, and teleICU. The firm offers technology platform, Telemed IQ that allows hospitals, health systems and other healthcare organizations the ability to provide telemedicine programs either with their its clinical team or in conjunction with its affiliated network of established, board-certified physicians and other provider specialists. Its cloud based Telemed IQ technology platform is an integrated and configurable technology solution that seamlessly combines voice, video, imaging, electronic medical record (EMR) integration, clinical workflow optimization, clinical resource management, analytics, predictive modeling and other reporting tools.
The current stock price of TLMD is 3 null.
TLMD does not pay a dividend.
TLMD has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
TLMD stock is listed on the Nasdaq exchange.
SOC TELEMED INC (TLMD) will report earnings on 2022-05-11.
ChartMill assigns a technical rating of 8 / 10 to TLMD. When comparing the yearly performance of all stocks, TLMD is one of the better performing stocks in the market, outperforming 96.95% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to TLMD. The financial health of TLMD is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months TLMD reported a non-GAAP Earnings per Share(EPS) of -2.45. The EPS decreased by -192688.57% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -69.61% | ||
| ROA | -31.66% | ||
| ROE | N/A | ||
| Debt/Equity | 0.41 |
12 analysts have analysed TLMD and the average price target is 3.06 null. This implies a price increase of 2% is expected in the next year compared to the current price of 3.
For the next year, analysts expect an EPS growth of -42.09% and a revenue growth 61.44% for TLMD